Omeprazole Capsules

Contract SPE2D2-24-D-0004 is an indefinite-delivery/indefinite-quantity award issued by DLA Troop Support to Golden State Medical Supply, Inc. for the procurement of Omeprazole 20 MG and 40 MG delayed-release capsules in various bottle counts. Originally awarded on February 28, 2024, with an estimated value of $28,836,471.10, the contract covers a base year and four option years. A subsequent modification, P00001, reduced the total contract value to $25,313,710.85. The most recent action, Modification P00005, exercised the second year option for the performance period of February 28, 2026, to February 27, 2027. The contract is managed as FOB Destination and includes rigorous compliance requirements under the Federal Acquisition Supply Chain Security Act, requiring the contractor to report and mitigate risks associated with restricted sources. Key administrative mandates include Item Unique Identification per DFARS 252.211-7003 and adherence to various FAR clauses regarding cybersecurity, whistleblower protections, and the prohibition of covered applications such as ByteDance. Performance is monitored through DLA Troop Support in Philadelphia, with supply chain transparency and quarterly SAM.gov reviews serving as primary deliverables.